These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 1578635)
1. [Clinical toxicity at the infusion of cryopreserved and thawed peripheral blood stem cell grafts in children]. Okamoto Y; Takaue Y; Yasutomo K; Saito S; Hirao A; Matsunaga K; Abe T; Shimizu T; Sato J; Watanabe T Rinsho Ketsueki; 1992 Mar; 33(3):317-21. PubMed ID: 1578635 [TBL] [Abstract][Full Text] [Related]
2. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells. Ozdemir E; Akgedik K; Akdogan S; Kansu E Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066 [TBL] [Abstract][Full Text] [Related]
3. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation. Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292 [TBL] [Abstract][Full Text] [Related]
4. [Relevant low toxicities with rhG-CSF mobilized and cryopreserved autologous peripheral blood stem cell return infusions in children]. Wang JW; Tang SQ; Lü SG; Ran CR; Yang G; Liu Y; Gao XN Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):404-7. PubMed ID: 17493357 [TBL] [Abstract][Full Text] [Related]
6. Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components. Rowley S; MacLeod B; Heimfeld S; Holmberg L; Bensinger W Cytotherapy; 1999; 1(4):311-7. PubMed ID: 20440908 [TBL] [Abstract][Full Text] [Related]
9. Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease. Mueller LP; Theurich S; Christopeit M; Grothe W; Muetherig A; Weber T; Guenther S; Behre G Eur J Haematol; 2007 Jun; 78(6):527-31. PubMed ID: 17509106 [TBL] [Abstract][Full Text] [Related]
10. Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer. Okamoto Y; Takaue Y; Saito S; Shimizu T; Suzue T; Abe T; Sato J; Hirao A; Watanabe T; Kawano Y Transfusion; 1993 Jul; 33(7):578-81. PubMed ID: 8101399 [TBL] [Abstract][Full Text] [Related]
11. [Successful hematologic reconstitution using CD34+ cells positively selected from cryopreserved autologous peripheral blood stem cells in a patient with malignant lymphoma]. Endo T; Sawada K; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T Rinsho Ketsueki; 2000 Aug; 41(8):681-6. PubMed ID: 11020998 [TBL] [Abstract][Full Text] [Related]
12. Cryopreserved autologous platelet transfusions in alloimmunized patients with acute leukemia. Wiesneth M; Koerner K; Funke I; Seifried E; Cardoso M; Heimpel H; Kubanek B Beitr Infusionsther; 1992; 30():297-300. PubMed ID: 1284720 [TBL] [Abstract][Full Text] [Related]
13. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Katayama Y; Yano T; Bessho A; Deguchi S; Sunami K; Mahmut N; Shinagawa K; Omoto E; Makino S; Miyamoto T; Mizuno S; Fukuda T; Eto T; Fujisaki T; Ohno Y; Inaba S; Niho Y; Harada M Bone Marrow Transplant; 1997 Feb; 19(3):283-7. PubMed ID: 9028559 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of engraftment after cryopreservation of peripheral blood stem cell autografts by controlled- versus uncontrolled-rate methods. Takaue Y; Abe T; Kawano Y; Suzue T; Saito S; Hirao A; Sato J; Makimoto A; Kawahito M; Watanabe T Bone Marrow Transplant; 1994 Jun; 13(6):801-4. PubMed ID: 7920317 [TBL] [Abstract][Full Text] [Related]
15. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate. Lemarie C; Calmels B; Malenfant C; Arneodo V; Blaise D; Viret F; Bouabdallah R; Ladaique P; Viens P; Chabannon C Transfusion; 2005 May; 45(5):737-42. PubMed ID: 15847663 [TBL] [Abstract][Full Text] [Related]
16. Toxicity of autologous bone marrow graft infusion. Davis J; Rowley SD; Santos GW Prog Clin Biol Res; 1990; 333():531-40. PubMed ID: 2308999 [TBL] [Abstract][Full Text] [Related]
17. Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. Porta MD; Rigolin GM; Alessandrino EP; Maiocchi M; Malcovati L; Vanelli L; Baratè C; Rumi E; Ciccone M; Cuneo A; Lazzarino M; Castoldi G Eur J Haematol; 2004 Jan; 72(1):18-25. PubMed ID: 14962258 [TBL] [Abstract][Full Text] [Related]
18. [Hemolytic uremic syndrome-like episode following nonmyeloablative hematopoietic stem cell transplantation in a patient with chronic myeloid leukemia]. Takahashi N; Miura I; Kume M; Kawabata Y; Hirokawa M; Sawada K Rinsho Ketsueki; 2003 Jun; 44(6):391-5. PubMed ID: 12884818 [TBL] [Abstract][Full Text] [Related]
19. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM. Lioznov M; Dellbrügger C; Sputtek A; Fehse B; Kröger N; Zander AR Bone Marrow Transplant; 2008 Jul; 42(2):121-8. PubMed ID: 18391988 [TBL] [Abstract][Full Text] [Related]
20. Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation. Neubauer MA; Benyunes MC; Thompson JA; Bensinger WI; Lindgren CG; Buckner CD; Fefer A Bone Marrow Transplant; 1994 Mar; 13(3):311-6. PubMed ID: 7911048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]